SAWAF AZIZ (SVP & CHIEF FINANCIAL OFFICER) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/22/2026ACC: 0001961289-26-000006
Officer· SVP & CHIEF FINANCIAL OFFICER
Since Feb 2026
-8.67K
Net shares
Net seller
$143.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
8.67K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−8.67K
Price / share
$16.55
Trade value
$143.49K
% of position
2.5%
5/20/2026
353.62K→344.95K
Total
Net shares
−8.67K
Net value
-$143.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/20/2026 | F · Tax Withholding | −8.67K | $16.55 | $143.49K | 2.5% | 353.62K | 344.95K |
| Total | −8.67K | -$143.49K | ||||||
Derivative Transactions0
No derivative transactions reported